VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Combination #5
Preclinical
Small molecule
U
University of Wuerzburg
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
HCV
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
HCV
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
HCV
1 trial
Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy
Unknown status
·
U
University of Wuerzburg
·
N/A
·
NCT02469012
·
30 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Combination #5. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Combination #5 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Combination #5. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Wuerzburg company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Wuerzburg
Related News